IntrinsiQ launches IntelliScribe eprescribing system for medical oncology
18 June 2010
IntrinsiQ, provider of IntelliDose, the leading chemotherapy management software, has launched IntelliScribe, the first integrated eprescribing system for medical oncology.
“Oncologists are prescribing an ever increasing number of oral medications. IntelliScribe gives them the tools to manage all of their prescribing needs in one location and create a unified chemotherapy record.”
Oncologists will now be able to manage complex chemotherapy drug orders — including oral and IV chemotherapy, antiemetics and pain medications — in one location, as part of the chemotherapy order. Streamlining practice efficiency, prescribers can conveniently submit electronic prescriptions while managing chemotherapy treatments. Every type of drug administered becomes part of the chemotherapy order: nothing is missed, contraindications are flagged, and the patient record is complete.
“Oncologists are prescribing an ever increasing number of oral medications. IntelliScribe gives them the tools to manage all of their prescribing needs in one location and create a unified chemotherapy record,” said Andrew Scott, director of product management, IntelliDose, a division of IntrinsiQ, LLC. “Integrating e-prescribe with chemotherapy regimen management creates a truly complete picture of the patient’s treatment history while enhancing efficiency, safety and ultimately the quality of patient care.”
Available now as a fully integrated component of IntelliDose, IntelliScribe is a full-featured e-prescribe solution. It can support all the e-prescribing needs of an entire practice, or for practices currently e-prescribing through an electronic medical record (EMR), IntelliScribe complements existing solutions to manage chemotherapy drug regimens.
“Our patients have a tremendous amount of information to deal with while receiving their treatment,” said Thomas J. Jean, manager of Frisbie Memorial Hospital, Center for Cancer Care in Rochester, New Hampshire. “IntelliScribe is yet another way to improve a patient’s experience during a time of intense stress. The script is ordered, verified and sent before the patient leaves the office, and the prescriptions are ready when they reach the pharmacy. There are no surprises and everything’s correct.”
“We see as many as 400 patients a day,” said Kathy Ross, practice administrator of Little Rock Hematology Oncology Associates, one of the largest private oncology practices in Arkansas. “IntelliScribe helps us meet e-Prescribe and Meaningful Use requirements and — along with IntelliDose — significantly enhances our quality of care and practice efficiency.”
Developed by oncologists to automate even the most complex aspects of medical oncology, IntelliDose transforms the manual process of chemotherapy regimen calculations into electronically verified orders. It allows oncology practices to standardize cancer treatment pathways, and ensure the highest levels of patient safety and efficiency practice-wide. IntelliDose interfaces with leading EMR and hospital information systems, extending existing or planned technology investments to include cancer patient management.